Efficacy and Tolerability of Valganciclovir 6 Months vs 6 Weeks in Symptomatic Cytomegalovirus Infection in Infants: An Open Level Randomized Controlled Trial. CLINICMED [Internet]. 2022 Jan. 11 [cited 2025 Oct. 11];3(1):18-25. Available from: https://ej-clinicmed.org/index.php/clinicmed/article/view/122